PerkinElmer Teams with Luminex to Develop Solutions for High Volume Disease Screening

PerkinElmer, Inc. (NYSE: PKI), a leading provider of drug discovery, life science research, and analytical solutions, and Luminex(R) Corporation (Nasdaq: LMNX), a leading multiplex solution developer, announced today a long-term licensing agreement to provide PerkinElmer access to Luminex's xMAP(R) technology and assay development capabilities of the Luminex Bioscience Group. Under the terms of the agreement, [...]

BD Announces Agreement to Acquire GeneOhm Sciences, Inc.

Franklin Lakes, NJ-BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it has signed an agreement to acquire GeneOhm Sciences, Inc., a privately held company headquartered in San Diego, California that has pioneered the development of molecular diagnostic testing for the rapid detection of bacterial organisms, including those known to cause healthcare-associated infections (HAIs). GeneOhm [...]

Invitrogen Awarded $970K Contract by U.S. Department of Defense for Production and Validation of Array-Based Biothreat Detection Platform

CARLSBAD, Calif.,-- Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science technologies for disease research and drug discovery, today announced that its subsidiary, Invitrogen Federal Systems, was awarded a $970K Technical Assistance Agreement by the U.S. Department of Defense to produce and validate protein microarrays to biothreat agents. This work will be conducted under the [...]

Pavilion Technologies and Thermo Electron Partner for Pharmaceutical Industry

AUSTIN, Texas – Pavilion Technologies, a world leader in advanced process control (APC) and environmental compliance solutions, and Thermo Electron, a world leader in analytical instruments, today announced a worldwide strategic joint marketing agreement to deliver complete solutions of software, process analyzers and consulting services to meet the pharmaceutical industry’s Process Analytical Technology (PAT) needs. [...]

Acacia to Spin Off DNA Microarray Subsidiary CombiMatrix

Newport Beach, CA —Acacia Research has approved a plan for its CombiMatrix subsidiary, a maker of DNA microarray consumables and instrumentation,to become an independent public company. The transaction is expected to be completed in the second quarter of 2006 with CombiMatrix listing its shares on the NASDAQ exchange. “This will benefit both companies by eliminating [...]

Aspectrics Corp Announces Receipt of its Fifth US Patent for Encoded-Photometric Infrared Technology

PLEASANTON, Calif., January 9, 2006 – Aspectrics, Inc., a leading supplier of Encoded Photometric Infrared Spectroscopy (EP-IR) analyzers, today announced the receipt of a fifth US patent for its Encoded Photometric Infrared Spectroscopy disk technology and associated optics. The new patent number 6,982,788 was filed May 29th, 2000, and issued January 3rd, 2006. “This patent [...]

Affymetrix Estimates $15 Million Shortfall for Fourth Quarter

Santa Clara, CA 1/5/05—Affymetrix has announced that it expects fourth quarter 2005 revenues of $115 million, $15 million below the company’s previous guidance of $120 million. Affymetrix estimates 2005 total revenues of $365 million, for annual growth of 5.5%, and 2005 product and product-related revenues of $350 million, for growth of 5.7%. In 2006, Affymetrix [...]

QIAGEN and Eppendorf Form Alliance for Development and Marketing of Life Science Solutions

Venlo , The Netherlands and Hamburg , Germany – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt , Prime Standard: QIA) and Eppendorf AG today announced that they have formed a strategic alliance that includes co-development and co-marketing of complementary and optimized products. The alliance is intended to link two of the strongest brands and product lines in [...]

GE Healthcare Completes IDX Acquisition

BARRINGTON, Ill., — GE Healthcare, a unit of General Electric Company (NYSE: GE), announced the completion of the company’s acquisition of IDX Systems Corporation (NASDAQ: IDXC), a leading healthcare information technology (IT) provider. GE expects the acquisition to accelerate efforts to seamlessly connect clinicians from physicians’ offices to hospitals with comprehensive, enterprise-wide electronic health record [...]

Applied Biosystems Acquires Ambion

Foster City, CA and Austin, TX —Applied Biosystems has signed a definitive agreement to acquire Ambion’s Research Products Division, a supplier of RNA-based reagents, for $273 million in cash. Ambion’s Research Products Division sells sample preparation, RNAi, micro RNA, and gene expression and array products. Ambion’s 2005 revenues are forecasted to increase 22% to more [...]

Access IBO on Knowledge Center